Search Within

Vicky Makker

Formats
  1. Meeting Abstract (142)
  2. Journal Article (110)
  3. Review (9)
  4. Editorial (3)
  5. Book Section (2)
  6. Guidelines (1)
Groups
  1. Department of Medicine (267)
  2. GDMT, Medicine (267)
  3. Gynecologic Medicine Service (267)
  4. Gynecology Disease Management Team (267)
  5. Solid Tumor Oncology Division (267)
  6. Surgery (94)

More Groups

People
  1. Carol Aghajanian (91)
  2. Nadeem Abu-Rustum (77)
  3. Mario Leitao (49)
  4. Alexia Iasonos (47)
  5. Kaled Alektiar (45)
  6. Qin Zhou (43)

More People

Years
  1. 2025 (11)
  2. 2024 (35)
  3. 2023 (39)
  4. 2022 (36)
  5. 2021 (19)
  6. 2020 (26)

More Years

Publications
  1. Gynecologic Oncology (65)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Gynecological Cancer (36)
  4. Annals of Oncology (23)
  5. Gynecologic Oncology Reports (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Elsevier Inc. (74)
  2. American Society of Clinical Oncology (61)
  3. Lippincott Williams & Wilkins (37)
  4. Oxford University Press (26)
  5. American Association for Cancer Research (12)
  6. Wiley Blackwell (9)

More Publishers

Results (267)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib study of miransertib (ARQ 092) in combination with anastrozole in patients with PIK3CA or AKT1-mutant ER+ endometrial or ovarian cancer
    Meeting Abstract

    Hyman, D.; Bonafede, M.; O'Cearbhaill, R.; Grisham, R.; Zamarin, D.; Tew, W.; Aghajanian, C.; Cadoo, K.; Friedman, C.; Savage, R. E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial
    Meeting Abstract

    Jhaveri, K. L.; Makker, V.; Wang, X. V.; Chen, A. P.; Flaherty, K.; Conley, B. A.; O'Dwyer, P. J.; Williams, P. M.; Hamilton, S. R.; Harris, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib study of binimetinib with paclitaxel in patients with platinum-resistant ovarian cancer: Final results, potential biomarkers, and extreme responders
    Journal Article

    Grisham, R. N.; Moore, K. N.; Gordon, M. S.; Harb, W.; Cody, G.; Halpenny, D. F.; Makker, V.; Aghajanian, C. A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment
    Journal Article

    Aloisi, A.; Casanova, J. M.; Tseng, J. H.; Seader, K. A.; Nguyen, N. T.; Alektiar, K. M.; Makker, V.; Chiang, S.; Soslow, R. A.; Leitao, M. M. Jr; more...
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy
    Journal Article

    Schlappe, B. A.; Weaver, A. L.; Ducie, J. A.; Eriksson, A. G. Z.; Dowdy, S. C.; Cliby, W. A.; Glaser, G. E.; Soslow, R. A.; Alektiar, K. M.; Makker, V.; more...
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Brain metastases in patients with low-grade endometrial carcinoma
    Journal Article

    Cybulska, P.; Stasenko, M.; Alter, R.; Makker, V.; Cadoo, K. A.; Sonoda, Y.; Abu-Rustum, N. R.; Mueller, J. J.; Leitao, M. M. Jr
    Gynecologic Oncology Reports (2018)

    Fulltext@MSK | Save
  • Phase I study of MEDI3617, a selective angiopoietin-2 inhibitor alone and combined with carboplatin/paclitaxel, paclitaxel, or bevacizumab for advanced solid tumors
    Journal Article

    Hyman, D. M.; Rizvi, N.; Natale, R.; Armstrong, D. K.; Birrer, M.; Recht, L.; Dotan, E.; Makker, V.; Kaley, T.; Kuruvilla, D.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Burger, R. A.; Deng, W.; Makker, V.; Collins, Y.; Gray, H.; Debernardo, R.; Martin, L. P.; Aghajanian, C.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer
    Journal Article

    LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save